Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

NCT02024932 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinal and Bulbar Muscular Atrophy

Interventions

DRUG: BVS857
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals